HEICO Corp. 10-Q Summary: Period Ended April 30, 1996
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended April 30, 1996, and the six-month period ended on that date. HEICO Corporation operates through two primary segments: HEICO Aerospace Corporation (aerospace products and services) and MediTek Health Corporation (health care services). The company reported 4,328,694 shares of common stock outstanding as of May 31, 1996. A three-for-two stock split was distributed on April 24, 1996, and all per-share data has been restated to reflect this event.
Key Financial Metrics
| Metric | Six Months Ended Apr 30, 1996 | Six Months Ended Apr 30, 1995 | Three Months Ended Apr 30, 1996 | Three Months Ended Apr 30, 1995 |
|---|---|---|---|---|
| Net Sales | $23,260,000 | $19,278,000 | $12,400,000 | $10,345,000 |
| Net Income | $1,952,000 | $1,221,000 | $1,082,000 | $652,000 |
| Diluted EPS | $0.41 | $0.29 | $0.22 | $0.15 |
| Operating Income | $3,127,000 | $1,941,000 | $1,800,000 | $1,032,000 |
| Cash from Operations | $2,374,000 | $2,566,000 | N/A | N/A |
| Cash and Equivalents (End) | $9,117,000 | $4,078,000 | N/A | N/A |
| Total Debt (Current + Long-term) | $7,202,000 | $7,870,000 | N/A | N/A |
Segment Margins (Six Months): HEICO Aerospace gross margin improved to 33.8% (from 31.4% prior year). MediTek gross margin declined to 26.2% (from 34.3% prior year) due to increased contractual allowances.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 21% year-over-year for the six-month period. Aerospace sales rose 27% driven by higher jet engine parts volume. MediTek sales rose 11% due to new center openings and MRI capability additions.
- Profitability: Net income surged 60% year-over-year for the six-month period. Operating income increased 61%.
- Partnership Performance: Equity in income of unconsolidated partnerships turned from a loss of $334,000 to income of $341,000, a $675,000 improvement, primarily due to a merger of a partnership center.
- Liquidity: Cash and cash equivalents more than doubled to $9.1 million, aided by the maturity of $2.9 million in short-term investments and strong operating cash flow.
- Backlog: HEICO Aerospace backlog increased to approximately $23 million from $14 million a year prior.
Outlook, Risks, and Management Commentary
Management Commentary: Improved results are attributed to volume increases and margin improvements in Aerospace, and operational improvements in MediTek's unconsolidated partnerships. SG&A expenses increased in absolute dollars but declined as a percentage of sales to 19.1%.
Legal and Regulatory Risks: In May 1996, Florida legislation retroactively repealed limitations on diagnostic imaging fees ("Fee Caps"). While this removes a regulatory constraint, the company notes ongoing litigation history regarding these caps. The repeal is generally viewed as favorable for providers.
Accounting Contingencies: The company is evaluating the impact of SFAS No. 123 (Stock-Based Compensation), which requires disclosure of pro forma earnings if fair value accounting is elected. The company has not yet determined if it will adopt the fair value method.
Unusual Items: The company wrote off equipment under capital leases with a net book value of $1.389 million and associated liabilities of $1.79 million upon lease termination in fiscal 1996.
Investor Verification Checklist
- MediTek Margins: Verify the sustainability of MediTek's gross margin decline (26.2% vs 34.3%) and the impact of contractual allowances in specific regions.
- Partnership Merger Impact: Confirm the long-term profitability of the merged unconsolidated partnership center that drove the swing from loss to income.
- Backlog Quality: Assess the $23 million Aerospace backlog, noting that $13 million represents forecasted shipments based on customer estimates rather than firm orders.
- Stock-Based Compensation: Monitor future filings for the company's decision on adopting SFAS No. 123 and the potential impact on reported net income.
- Debt Structure: Review the composition of the $7.2 million total debt, specifically the current maturities of $1.236 million, to ensure adequate liquidity coverage.